Showing results (1201-1210 of 1,243) with videos related to
Sort By:
Pageof 125
JAMA|February 22, 2023
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical TrialSusanna Naggie, David R Boulware, Christopher J Lindsell, et al.Circulation|August 27, 2022
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER TrialJawad H Butt, Pardeep S Jhund, Jan Belohlávek, et al.JAMA Internal Medicine|July 14, 2025
Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical TrialCarolyn T Bramante, Thomas G Stewart, David R Boulware, et al.Medrxiv : the Preprint Server for Health Sciences|October 1, 2025
Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical TrialCarolyn T Bramante, Thomas G Stewart, David R Boulware, et al.Journal of Cardiac Failure|June 9, 2015
Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations From the Heart Failure Society of America Guideline CommitteeMonica Colvin, Nancy K Sweitzer, Nancy M Albert, et al.Circulation|April 1, 2022
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.Circulation|April 1, 2022
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.Journal of Cardiac Failure|April 4, 2022
2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive SummaryPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.Lancet (London, England)|September 2, 2025
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trialsFaiez Zannad, Christopher M O'Connor, Javed Butler, et al.Journal of Cardiac Failure|May 9, 2015
Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines CommitteeJames C Fang, Gregory A Ewald, Larry A Allen, et al.Pageof 125